content top

Reasons for Aflibercept Prescription in Wet AMD in Real Life

Media not available due to technical recording problems. EVRS is very sorry for the inconvenience.   Purpose: To describe the main reason for aflibercept prescription in the treatment of exudative age-related macular degeneration (AMD) during the initial weeks of availability of this drug in a clinical setting. Patients and methods: During the first 16 weeks of availability in France, four experienced practitioners in retinal disease...

Read More

Bevacizumab for Subfoveal Choroidal Neovascularization in a Child

Poster Gavin Tan Introduction: Choroidal neovascularization (CNV) is rare but important cause of visual impairment in children. It is often idiopathic or secondary to inflammation, optic nerve head abnormalities or retinal dystrophies. There is a lack of clinical trials assessing the treatment of CNV in children. Methods: A 11-year-old boy with no past medical or ocular history presented with 3 months duration of reduced vision in his...

Read More

MH After Intravitreal Ranibizumab Injection for DME

Poster Jaeryung Oh Purpose: To report a case of macular hole formed after intravitreal ranibizumab injection in diabetic macular edema. Case summary: A 76-year-old woman with a 30-year history of type 2 diabetes visited the clinic presenting with the complaint of decreased vision in her right eye. The best-corrected visual acuity of the right eye was 6/20, and 6/12 in the left eye. Intraocular pressure was 20 mmHg in her right eye and she...

Read More

Expression Pattern of Extracellular Matrix Components After Ranibizumab for Neovascular ARMD

Poster Malgorzata Nita Purpose: The aim of the study was to evaluate the effect of loading doses of ranibizumab on gene expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in patients with CNV/AMD. Setting: Study was conducted by the Department of Ophthalmology, Medical University of Silesia, Independent Public Clinical Hospital, Katowice, Poland. Methods Inclusion criteria: patients ≥60...

Read More

Efficacy of Intravitreal Anti-vascular Endothelial Growth Factor in Acute Central Serous Chorioretinopathy: One-Year Results

To evaluate the 1-year efficacy of intravitreal anti-vascular endothelial growth factor (anti-VEGF) in patients with acute central serous chorioretinopathy (CSC).

Read More

Three Consecutive Loading Dose of Ranibizumab for the Treatment of Retinal Angiomatous Proliferation

Purpose: To evaluate the 12 months functional outcome and morphological changes according stages after 3 monthly intravitreal ranibizumab injections for the treatment of retinal angiomatous proliferation (RAP) in Korea. Methods: A retrospective chart review of 40 patients (41 eyes) with RAP was conducted. Patients received three initial monthly intravitreal injections (0.5 mg) of ranibizumab and monitored monthly for 12 months....

Read More
content top